tirzepatide cause yeast infection Does Mounjaro (tirzepatide) increase the frequency of vaginal candidiasis (thrush)? Mounjaro long-term side effects: What

Its a new era, said FDA commissioner Marty Makary, MD, in the agencys press release

Longer-term outcomes arent yet known

Factors include baseline metabolic rate, duration of tirzepatide use, underlying glucose dysregulation, and pre-treatment weight history

Studies, including placebo-controlled trials comparing tirzepatide to other treatment regimens, have demonstrated mean body weight reductions and improvements in weight-related comorbidities such as chronic kidney disease and obstructive sleep apnea

Clinical trials have shown that the highest doses of Mounjaro and Wegovy are almost equally effective, with Wegovy 7.2mg associated with an average 21% weight loss, compared with people taking 15mg of Mounjaro per week, who lose an average of 22.5% of their starting body weight over 72 weeks